Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk management plans (English, HTML)

View metadata and access the original English HTML file: Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk management plans.

Format

HTML

Access

file-only

Publisher-reported update

2024-04-04

We are issuing this notice to help drug manufacturers and sponsors when preparing the Canadian-specific considerations and elements in the risk management plans (RMPs) for certain drug products. This notice describes what is required for certain drug products.

Access original file